Alden Meadow Park Hcc | |
709 Meadow Park Dr, Clinton, Wisconsin 53525 | |
(608) 676-2202 | |
Name | Alden Meadow Park Hcc |
---|---|
Location | 709 Meadow Park Dr, Clinton, Wisconsin |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 94 |
Occupancy Rate | 58.62% |
Medicare ID (CCN) | 525508 |
Legal Business Name | Alden-meadow Park Health Care Center, Inc. |
Ownership Type | For Profit - Corporation |
NPI Number | 1083601405 |
Organization Name | ALDEN-MEADOW PARK HEALTH CARE CENTER, INC. |
Address | 709 Meadow Park Dr, Clinton, WI 53525 |
Phone Number | 608-676-2202 |
News Archive
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are pleased to announce the collaborative development of the Practice Guideline for the Performance of an Ultrasound Examination in the Practice of Urology.
BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia, was presented in a poster at the Annual Meeting of the American Society of Hematology, which took place on December 7-10, 2013.
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has classified its letters to physicians related to the incompatibility of its Sutureless Connector (SC) intrathecal catheters with the IsoMed constant-flow infusion pumps as a Class I recall.
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
› Verified 9 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are pleased to announce the collaborative development of the Practice Guideline for the Performance of an Ultrasound Examination in the Practice of Urology.
BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia, was presented in a poster at the Annual Meeting of the American Society of Hematology, which took place on December 7-10, 2013.
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has classified its letters to physicians related to the incompatibility of its Sutureless Connector (SC) intrathecal catheters with the IsoMed constant-flow infusion pumps as a Class I recall.
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
› Verified 9 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $7150 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 14.69 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.91 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 41.94 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.53 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 3.14 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.48 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.5 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 9.71 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 75.31 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.65 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 14.85 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.12 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 3.77 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 82.19 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 80.06 | 82.93 |
News Archive
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.
The American Institute of Ultrasound in Medicine (AIUM) and American Urological Association (AUA) are pleased to announce the collaborative development of the Practice Guideline for the Performance of an Ultrasound Examination in the Practice of Urology.
BerGenBio AS, an oncology biopharmaceutical company, announces that preclinical data demonstrating that BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia, was presented in a poster at the Annual Meeting of the American Society of Hematology, which took place on December 7-10, 2013.
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has classified its letters to physicians related to the incompatibility of its Sutureless Connector (SC) intrathecal catheters with the IsoMed constant-flow infusion pumps as a Class I recall.
Domainex Ltd., the Contract Research Organization committed to excellence in drug discovery, today announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulate DNA expression and can be critical to cancer and stem cell biology research. Funding from the UK Government-backed Technology Strategy Board will support this work.
› Verified 9 days ago